Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)

BACKGROUND: The relapse rate in early stage non-small cell lung cancer (NSCLC) after surgical resection is high. Prognostic biomarkers may help identify patients who may benefit from additional therapy. The Helicase-like Transcription Factor (HLTF) is a tumor suppressor, altered in cancer either by...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Dhont, Ludovic, Pintilie, Melania, Kaufman, Ethan, Navab, Roya, Tam, Shirley, Burny, Arsène, Shepherd, Frances, Belayew, Alexandra, Tsao, Ming-Sound, Mascaux, Céline
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5902896/
https://ncbi.nlm.nih.gov/pubmed/29661164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4215-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires